PRV-1 overexpression in essential thrombocythemia correlates with trail expression (2011)
- Authors:
- USP affiliated authors: COVAS, DIMAS TADEU - FMRP ; SIMOES, BELINDA PINTO - FMRP ; CASTRO, FABÍOLA ATTIÉ DE - FCFRP ; SOUZA, ANA MARIA DE - FCFRP
- Schools: FMRP; FCFRP
- Subjects: EXPRESSÃO GÊNICA; DOENÇAS HEMATOLÓGICAS; LEUCÓCITOS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Haematologica
- ISSN: 0390-6078
- Volume/Número/Paginação/Ano: v. 96, suppl. 2, p. 136, res. 0328, 2011
- Conference title: Congress of The European Hematology Association
-
ABNT
TOGNON, R. et al. PRV-1 overexpression in essential thrombocythemia correlates with trail expression. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 06 jul. 2022. , 2011 -
APA
Tognon, R., Neves, R., Nunes, N., Gasparotto, E., Kashima, S., Covas, D. T., et al. (2011). PRV-1 overexpression in essential thrombocythemia correlates with trail expression. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Tognon R, Neves R, Nunes N, Gasparotto E, Kashima S, Covas DT, Santana M, Souto E, Zanichelli M, Velano C, Simoes BP, Souza AM de, Castro FA de. PRV-1 overexpression in essential thrombocythemia correlates with trail expression. Haematologica. 2011 ; 96 136.[citado 2022 jul. 06 ] -
Vancouver
Tognon R, Neves R, Nunes N, Gasparotto E, Kashima S, Covas DT, Santana M, Souto E, Zanichelli M, Velano C, Simoes BP, Souza AM de, Castro FA de. PRV-1 overexpression in essential thrombocythemia correlates with trail expression. Haematologica. 2011 ; 96 136.[citado 2022 jul. 06 ] - Differential expression of the flice-inhibitory protein, C-flip, in 'CD34 POT.+'cells in chronic myelogenous leukemia, polycythemia vera and essential trombocythemia
- Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in essential thrombocythemia and myelofibrosis
- Apoptomirs expression profile in polycythemia vera patients
- Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta]
- Deregulated expression of A1, Bcl-2, Bcl-xL, and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients
- Apoptosis-related gene expression profile in chronic myeloid leukemia patients after imatinib mesylate and dasatinib therapy
- Differential expression of the flice-inhibitory protein, c-flip, in cd34+ cells myelogenous leukemia, polycythemia vera and essential thombocythemia
- ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance
- The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms
- Tyrosine kinase inhibitors modulate the apoptomirs: MIR-16, MIR-21, MIR-30E, MIR-145, MIR-142-3P, MIR-LET-7D, MIR-LET-7E and MIR-15A expression in BCR-ABL-positive cell
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
